Concepedia
Statistics
Publications
10
Citations
2.2K
H-Index
Active since
1997
Affiliations
Calithera (United States)(Current)
University of California, San Francisco
The University of Texas MD Anderson Cancer Center
Johns Hopkins University
Langley Porter Psychiatric Hospital and Clinics
Peter J. Shwonek is an author at Calithera (United States) specializing in pharmacology, oncology, and medicine.
Publications per year
1997–2016
Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
Matt I. Gross, Susan D. Demo, Jennifer B. Dennison et al. · Molecular Cancer Therapeutics · 2014 · 1.1K citations
Medicine, Oncology, Pharmacology +16
A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis
Tony Muchamuel, Michael Basler, Monette Aujay et al. · Nature Medicine · 2009 · 595 citations
Life Sciences, Immunology, Pathology +17
Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)
Han-Jie Zhou, Monette Aujay, Mark K. Bennett et al. · Journal of Medicinal Chemistry · 2009 · 272 citations · Full text
Medicine, Oncology, Pharmacology +12
Buprenorphine Pharmacokinetics: Relative Bioavailability of Sublingual Tablet and Liquid Formulations
Rajneesh Nath, Robert A. Upton, E. Thomas Everhart et al. · The Journal of Clinical Pharmacology · 1999 · 124 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
Subnanogram-concentration measurement of buprenorphine in human plasma by electron-capture capillary gas chromatography: application to pharmacokinetics of sublingual buprenorphine.
E. Thomas Everhart, Polly Cheung, Peter J. Shwonek et al. · PubMed · 1997 · 45 citations
Pharmacy, Pharmacokinetics, Pharmacology +14
1–5 of 10